Effectiveness of autologous haematopoietic stem cell transplantation in comparison with natalizumab in progressive MS

被引:0
|
作者
Kalincik, T. [1 ,2 ]
Sharmin, S. [2 ]
Roos, I. [1 ,2 ]
Massey, J. [3 ,4 ]
Sutton, I. [3 ,4 ]
Withers, B. [4 ,5 ]
Freedman, M. [6 ]
Atkins, H. [6 ]
Horakova, D. [7 ,8 ,9 ]
Havrdova, E. Kubala [7 ,8 ,9 ]
Krasulova, E. [7 ,8 ,9 ]
Trneny, M. [7 ,10 ]
Kozak, T. [10 ,11 ]
Burman, J. [12 ]
Macdonell, R. [13 ,14 ]
Grigg, A. [14 ,15 ]
Torkildsen, O. [16 ]
Bo, L. [16 ]
Lehmann, A. K. [17 ]
Sharrack, B. [18 ]
Snowden, J. [19 ]
机构
[1] Royal Melbourne Hosp, MS Ctr, Melbourne, Australia
[2] Univ Melbourne, CORE, Melbourne, Australia
[3] St Vincents Hosp, Neurol, Sydney, Australia
[4] Univ Sydney, Sydney, Australia
[5] St Vincents Hosp, Haematol, Sydney, Australia
[6] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada
[7] Gen Univ Hosp, Prague, Czech Republic
[8] Charles Univ Prague, Dept Neurol, Prague, Czech Republic
[9] Ctr Clin Neurosci, Prague, Czech Republic
[10] Charles Univ Prague, Dept Haematol, Prague, Czech Republic
[11] Univ Hosp Kralovske Vinohrady, Prague, Czech Republic
[12] Uppsala Univ Hosp, Neurol, Uppsala, Sweden
[13] Austin Hlth, Neurol, Melbourne, Australia
[14] Univ Melbourne, Melbourne, Australia
[15] Austin Hlth, Haematol, Melbourne, Australia
[16] Haukeland Hosp, Neurol, Bergen, Norway
[17] Haukeland Hosp, Haematol, Bergen, Norway
[18] Sheffield Teaching Hosp NHS Fdn Trust, Dept Neurol, Sheffield, England
[19] Sheffield Teaching Hosp NHS Fdn Trust, Dept Haematol, Sheffield, England
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
O181
引用
收藏
页码:953 / 954
页数:2
相关论文
共 50 条
  • [21] Safety profile of autologous haematopoietic stem cell transplantation following natalizumab therapy in aggressive forms of multiple sclerosis
    Mariottini, A.
    Innocenti, C.
    Repice, A. M.
    Fani, A.
    Massacesi, L.
    Saccardi, R.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 768 - 769
  • [22] Clinical outcomes after autologous haematopoietic stem cell transplantation in patients with progressive multiple sclerosis
    Xu Juan
    Ji Bing-xin
    Su Li
    Dong Hui-qing
    Sun Xue-jing
    Liu Cong-yan
    CHINESE MEDICAL JOURNAL, 2006, 119 (22) : 1851 - 1855
  • [23] Autologous haematopoietic stem cell transplantation for neurological diseases
    Burman, Joachim
    Tolf, Andreas
    Hagglund, Hans
    Askmark, Hakan
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (02): : 147 - 155
  • [24] Clinical outcomes after autologous haematopoietic stem cell transplantation in patients with progressive multiple sclerosis
    XU Juan JI Bingxin SU Li DONG Huiqing SUN Xuejing and LIU Congyan Department of Haematology Department of Neurology Xuanwu HospitalCapital University of Medical Sciences Beijing China
    Chinese Medical Journal, 2006, (22) : 1851 - 1855
  • [25] Nursing appointment in autologous haematopoietic stem cell transplantation
    Carreiro, L.
    Goncalves, C.
    Damiao, C.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 429 - 430
  • [26] Polymyositis following autologous haematopoietic stem cell transplantation
    Hedermann, G.
    Marquart, H. V.
    Vissing, J.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 (05) : 429 - 431
  • [27] Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation
    Marco Capobianco
    Y. Motuzova
    J. Frau
    E. Cocco
    E. Mamusa
    M. G. Marrosu
    A. Bertolotto
    Neurological Sciences, 2012, 33 : 863 - 867
  • [28] Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation
    Capobianco, Marco
    Motuzova, Y.
    Frau, J.
    Cocco, E.
    Mamusa, E.
    Marrosu, M. G.
    Bertolotto, A.
    NEUROLOGICAL SCIENCES, 2012, 33 (04) : 863 - 867
  • [29] A prospective comparison of immune reconstitution after autologous haematopoietic stem cell transplantation in children
    Wiegering, V
    Winkler, B
    Eyrich, M
    Schlegel, PG
    BONE MARROW TRANSPLANTATION, 2006, 37 : S329 - S329
  • [30] Rebound of disease activity after discontinuation of natalizumab or fingolimod can be successfully treated with autologous haematopoietic stem cell transplantation
    Curro, D.
    Gualandi, F.
    Cavalla, P.
    Capello, E.
    Uccelli, A.
    Mattioda, A.
    Boffa, G.
    Mancardi, G.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 621 - 622